Window-to-China

Overview of last view News

Yuan Long Ping High Tech Agriculture Co: China’s number one seed company

Formed in 1999 and listed in 2000, Long Ping HighTech is China’s largest and most advanced seed company, with sales of Long ping High-Tech has a focus on new crops variety breeding or innovation; seeds multiplication; seeds sales and extension system of hybrid rice, hybrid pepper, hybrid rape, hybrid corn, hybrid cotton, musk melon and vegetables with high quality etc .Till the end of 2004, the total assets of Long ping High-Tech has reached at 1.2 billion yuan, and the sales revenue has reached at 1 billion yuan.

China Bio news release, March 11, 2014

Muyang Group, Yangzhou, sets up R&D center in Denmark

Muyang Group is specialized in feed and food machinery with a Chinese market share of 50 %. It has about 4.500 employees. The Denmark expansion is planned to test equipment for biomass to energy conversion.

China Bio news release, March 11, 2014

China develops transgenic corn based on independent IP

Based on developments by Peking University and CAAS Institute of Biotechnology, glyphosate-resistant corn was developed based on a proprietary G2-EPSPS gene. After approval by the Ministry of Agriculture in 2012, several rounds of breeding were done since and it is expected that several transgenic corn varieties with improved traits will be widely planted within 2 – 3 years.

China Bio news release, March 10, 2014

CAS Guangzhou Institutes of Biomedicine and Health develop ALS mini-pigs

In collaboration with CAS Institute of Genetics and Developmental Biology, researchers around Liangxue LAI developed Tibet mini-pig mutants which will develop amyotrophic lateral sclerosis (ALS) within a few months. To this end, a mutant human SOD1 gene was expressed using somatic cell nuclear transfer. The pigs will be used to study the mechanism and therapy of this disease.

Huaqiang YANG et al., Cell Research 2014, doi 10.1038/cr.2014.25

Team at CAS Tianjin Institute of Industrial Biotechnology elucidate pentose metabolism in Neurospora crassa

Using transcriptomics, the group around Dr Chaoguang TIAN found out that arabinose induces various transporters, transcription factors and enzymes well, but not xylose. Several new factors such as glucose transfer protein (GLT-1), pentose transporterx XYT-1 and XAT-1) and a xylanase regulatory factor (HCR-1) were identified which may help to enhance the metabolism of xylose in this organism

CAS news release, March 7, 2014

Shanxi Sequoia Pharmacuetical Co. acquires US Cardium Therapeutics, San Diego.

Shanxi Sequoia Co. is engaged in biomedical R&D with a focus on Taxol. It owns thousands of acres of yew trees in Shanxi. Cardium Therapeutics has its focus on the treatment of cardiovascular disease and vascular regeneration, including wound healing and tissue engineering.

China Bio news release, March 6, 2014

CAS Chengdu Institute of Biology analyzes use of thermotolerant yeast for bioethanol production

In an attempt to identify breeding targets for bioethanol production at elevated temperature, a team around Qian CHEN analyzed thermotolerant yeast strain M206111 transcriptomics during ethanol production above 37 °C. Parameters relevant to bioethanol production, e. g., trehalose accumulation and heat shock protein production, were identified.

Qian CHEN et al., Annals of Microbiology, 2013,4 (63) :1433-1440

CAAS team solves genome of sesame (Sesamum indicum L)

The group around Xiurong ZHANG reports a high-quality genome sequence of the 2.1 Mb genome, containing an estimated 27,148 genes. The results reveal novel, independent whole genome duplication. Candidate genes and oil biosynthetic pathways contributing to high oil content were discovered by comparative genomic and transcriptomic analyses.

Linhai WANG et al., Genome Biology doi:10.1186/gb-2014-15-2-r39

Chinese vaccine manufactuerers produce 60 kinds of vaccines, 34 against infectious diseases.

Total capacity is said to be 1 billion doses per year under a revised pharmaceutical GMP, according to WHO standards. Smallpox is eradicated, since 2000, China is polio-free, and children under 5 years carrying the hepatitis B surface antigen was down to 0.96 % in 2006. Chengdu Institute of Biological Products is among the WHO-classified laboratories for the production of live attenuated Japanese encephalitis vaccine.

China Bio news release, March 3, 2014

CAS Institute of Industrial Biotechnology, Tianjin, establishs E. coli cell factory for ß-carotene production

The group of Professor ZHANG Xueli has announced that through combined engineering of MEP, β-carotene synthesis, TCA, pentose phosphate and ATP synthesis modules, a genetically stable Escherichia coli strain was obtained which exhibited 74-fold yield increase over the wild type. This strain produced 2.1 g/L β-carotene with a yield of 60 mg/g.

CAS news release, March 3, 2014

Gansu Province tests consumer acceptance of GM food

Since January 2, 2014, GM-labeled food is offered at specially labeled counters in a supermarket in Lanzhou, Gansu province. The program is considered to help consumers make a choice between GM- and non-GM-food such as salad oil offered side by side. The idea is to discuss GM-related issues with consumers, to improve on the current GM food labeling , and to offer consumers a free choice.

China Bio news release, March 3, 2014

China’s National Gene Bank builds largest database of birth defects

Samples of birth defects number close to 13.000, and genetic data over 5.000. The number of birth defects in China is about 5.6 %, with an annual increase of about 900.000. Mr ZHANG Yong, head of the National Gene Bank, hopes to elucidate origin of birth defects by genetic and sample collection throughout China.

China Bio news release, March 2, 2014